We demonstrated that the upregulation of LAT1 in pemetrexed-resistant NSCLC cells is associated with increased CSC activity and the inhibition of LAT1 by RNA interference or JPH203 suppressing the self-renewal capability, which is mediated through the Akt/mTOR pathway. Here, MTOR is linked to non-small cell lung carcinoma.